On the generation of allergic airway diseases: From GM-CSF to Kyoto

Trends in Immunology

Volumn 23, Issue 8, 2002, Pages 396-402

  Ritz, Stacey A ^a   Stämpfli, Martin R ^a   Davies, Donna E ^b   Holgate, Stephen T ^b   Jordana, Manel ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY; ALLERGIC DISEASE; ANTIGEN PRESENTATION; ASTHMA; CELLULAR IMMUNITY; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RESPIRATORY TRACT DISEASE; REVIEW; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; ASTHMA; ENVIRONMENT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; TH2 CELLS;

EID: 0036680014     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(02)02278-0     Document Type: Review

References (68)

1. The epidemic of allergy and asthma
2. Infection: Friend or foe in the development of atopy and asthma? The epidemiological evidence
3. The coming-of-age of the hygiene hypothesis
4. Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation
5. Identification and functional characterization of human CD4+ CD25+ T cells with regulatory properties isolated from peripheral blood
6. Human CD25+ CD4+ T regulatory cells suppress naïve and memory T cell proliferation and can be expanded in vitro without loss of function
7. Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood
8. Allergy, parasites, and the hygiene hypothesis
9. How much asthma is really attributable to atopy?
10. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma
11. Kinetics of the development and recovery of the lung from IgE-mediated inflammation: Dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines
12. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge
13. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma: Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor
14. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients
15. Eosinophil-adhesion-inducing activity produced by antigen-stimulated mononuclear cells involves GM-CSF
16. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma
17. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis
18. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis
19. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis
20. Exposure to systemic prednisolone for 4 hours reduces ex vivo synthesis of GM-CSF by bronchoalveolar lavage cells and blood mononuclear cells of mild allergic asthmatics
21. Enhancement of eosinophil survival by lipopolysaccharide through releasing granulocyte-macrophage colony-stimulating factor from mononuclear cells from patients with bronchial asthma
22. Interleukin-12 inhibits production of interleukin-5 but not of granulocyte/macrophage colony-stimulating factor by antigen-stimulated blood mononuclear cells in allergic bronchial asthmatics
23. Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and from atopic asthmatic patients in vitro
24. Bronchial epithelial cells of atopic patients with asthma lack the ability to inactivate allergens
25. Differences between cytokine release from bronchial epithelial cells of asthmatic patients and non-asthmatic subjects: Effect of exposure to diesel exhaust particles
26. A variant in the gene for GM-CSF, I117T, is associated with atopic asthma in a Swiss population of asthmatic children
27. Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness
28. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice
29. Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation
30. Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: Essential role of GM-CSF
31. q signalling is required for allergen-induced pulmonary eosinophilia
32. Effects of budesonide and formoterol on NF-κB, adhesion molecules, and cytokines in asthma
33. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin
34. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways
35. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
36. Comparison of the functional properties of murine dendritic cells generated in vivo with flt3 ligand, GM-CSF, and flt3 ligand plus GM-CSF
37. Role of hematopoietic growth factors/flt3 ligand in expansion and regulation of dendritic cells
38. Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response
39. + subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo
40. Determinants of the immune-inflammatory response in allergic airway inflammation: Overview of antigen presentation and cellular activation
41. Dendritic cell regulation of Th1-Th2 development
42. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
43. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation
44. Regulation of allergic mucosal sensitization by interleukin-12 gene transfer to the airway
45. Myeloid dendritic cells stimulate both Th1 and Th2 immune responses depending on the nature of the antigen
46. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells
47. Eosinophil peroxidase stimulates the release of granulocyte-macrophage colony stimulating-factor from bronchial epithelial cells
48. Airway inflammation and remodelling in asthma - Cause and effect
49. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma
50. The effect of age and duration of disease on airway structure in fatal asthma
51. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts
52. Airway smooth muscle cells: Contribution to and regulating airway mucosal inflammation
53. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells
54. Protease-activated receptors in human airways: Upregulation of PAR-2 in respiratory epithelium from patients with asthma
55. Oncostatin M synergises with house dust mite proteases to induce the production of PGE2 from cultured lung epithelial cells
56. Particulate matter induces cytokine expression in human bronchial epithelial cells
57. Diesel exhaust particles activate human bronchial epithelial cells to express inflammatory mediators in the airways: A review
58. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro
59. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy
60. Diesel exhaust particles enhance antigen-induce airway inflammation and local cytokine expression in mice
61. Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa
62. Secondhand smoke induces allergic sensitization in mice
63. Effects of ozone on ovalbumin sensitization in guinea pigs
64. Asthma in exercising children exposed to ozone: A cohort study
65. The bidirectional capacity of bacterial antigens to modulate allergy and asthma
66. Granulocyte-macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis
67. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized General Practice data
68. Clean living increases more than just atopic disease